Project Grant HT94252410796
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$241K
Federal Agency
Defense Health Agency
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Hamden, CT 06511, USA
Similar Awards
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $2,027,311 to The Trustees of the University of Pennsylvania to conduct research on suicide prevention implementation strategies for the National Guard. The award period runs from September 1, 2024 to August 31, 2028. The research aims to transform healthcare for military service members by investigating innovative approaches to address critical health...
This federal Project Grant award for $859,773.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at Yale University aimed at transforming healthcare for military service members, veterans, and the broader public. The research project focuses on investigating biomarkers and targets of leptomeningeal disease progression from non-small cell lung cancer brain metastasis. The award has a performance...
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
This $460,279 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research on "Loss of Proteostasis and Vascular Amyloidosis" at Yale University. The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions for the battlefield and addressing critical health challenges. The 2-year grant,...
The U.S. Defense Health Agency awarded a $1,213,276 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2023 through August 31, 2026, will fund research on the role of vascular mimicry in the outgrowth of dormant melanoma micrometastases. The goal of this research is to transform health care for Service Members and the American public through innovative and impactful medical research on solutions...
This Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The $837,497 award to Yale University will fund research to investigate how "feeding stress primes the pancreas for cancer" over a performance period from November 1, 2024 to October 31, 2027. The grant supports...
The Defense Health Agency has awarded a $1,674,999.00 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). The grant is for the "PERTURBOMICS IDENTIFICATION OF CRITICAL GENETIC TARGETS IN NK CELLS FOR BREAST CANCER THERAPY" project, which will be conducted from September 1, 2023 to August 31, 2026. The funding will support basic, applied, and advanced biomedical research to transform healthcare for service members and the public...
This $1,675,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at Yale University aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, titled "Drug Discovery for Dystonia and Frontotemporal Degeneration," will be conducted over a 4-year period from August 2025 to August 2029. The work at Yale University is expected...
The federal Project Grant award of $249,612.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is funding research by Yale University to unravel the causal impact of multiple sclerosis (MS)-associated genetic variants on T cell immune tolerance. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing the understanding of MS pathogenesis through...
The Yale University was awarded a $1,244,745 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2021 to June 2025 to overcome resistance to EGFR inhibitors in advanced head and neck cancers. The Military Medical Research and Development program supports biomedical research to transform military and public health care through innovative solutions. This award will further...